Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antipsychotic
1.2.3 Hypnotic & Sedative
1.2.4 Analgesics
1.2.5 Anticoagulants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Disorder Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurological Disorder Drugs Market Perspective (2018-2029)
2.2 Global Neurological Disorder Drugs Growth Trends by Region
2.2.1 Neurological Disorder Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neurological Disorder Drugs Historic Market Size by Region (2018-2023)
2.2.3 Neurological Disorder Drugs Forecasted Market Size by Region (2024-2029)
2.3 Neurological Disorder Drugs Market Dynamics
2.3.1 Neurological Disorder Drugs Industry Trends
2.3.2 Neurological Disorder Drugs Market Drivers
2.3.3 Neurological Disorder Drugs Market Challenges
2.3.4 Neurological Disorder Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurological Disorder Drugs by Players
3.1.1 Global Neurological Disorder Drugs Revenue by Players (2018-2023)
3.1.2 Global Neurological Disorder Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurological Disorder Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Neurological Disorder Drugs Market Concentration Ratio
3.4.1 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurological Disorder Drugs Revenue in 2022
3.5 Global Key Players of Neurological Disorder Drugs Head office and Area Served
3.6 Global Key Players of Neurological Disorder Drugs, Product and Application
3.7 Global Key Players of Neurological Disorder Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurological Disorder Drugs Breakdown Data by Type
4.1 Global Neurological Disorder Drugs Historic Market Size by Type (2018-2023)
4.2 Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2029)
5 Neurological Disorder Drugs Breakdown Data by Application
5.1 Global Neurological Disorder Drugs Historic Market Size by Application (2018-2023)
5.2 Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neurological Disorder Drugs Market Size (2018-2029)
6.2 North America Neurological Disorder Drugs Market Size by Type
6.2.1 North America Neurological Disorder Drugs Market Size by Type (2018-2023)
6.2.2 North America Neurological Disorder Drugs Market Size by Type (2024-2029)
6.2.3 North America Neurological Disorder Drugs Market Share by Type (2018-2029)
6.3 North America Neurological Disorder Drugs Market Size by Application
6.3.1 North America Neurological Disorder Drugs Market Size by Application (2018-2023)
6.3.2 North America Neurological Disorder Drugs Market Size by Application (2024-2029)
6.3.3 North America Neurological Disorder Drugs Market Share by Application (2018-2029)
6.4 North America Neurological Disorder Drugs Market Size by Country
6.4.1 North America Neurological Disorder Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Neurological Disorder Drugs Market Size by Country (2018-2023)
6.4.3 North America Neurological Disorder Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Neurological Disorder Drugs Market Size (2018-2029)
7.2 Europe Neurological Disorder Drugs Market Size by Type
7.2.1 Europe Neurological Disorder Drugs Market Size by Type (2018-2023)
7.2.2 Europe Neurological Disorder Drugs Market Size by Type (2024-2029)
7.2.3 Europe Neurological Disorder Drugs Market Share by Type (2018-2029)
7.3 Europe Neurological Disorder Drugs Market Size by Application
7.3.1 Europe Neurological Disorder Drugs Market Size by Application (2018-2023)
7.3.2 Europe Neurological Disorder Drugs Market Size by Application (2024-2029)
7.3.3 Europe Neurological Disorder Drugs Market Share by Application (2018-2029)
7.4 Europe Neurological Disorder Drugs Market Size by Country
7.4.1 Europe Neurological Disorder Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Neurological Disorder Drugs Market Size by Country (2018-2023)
7.4.3 Europe Neurological Disorder Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurological Disorder Drugs Market Size (2018-2029)
8.2 China Neurological Disorder Drugs Market Size by Type
8.2.1 China Neurological Disorder Drugs Market Size by Type (2018-2023)
8.2.2 China Neurological Disorder Drugs Market Size by Type (2024-2029)
8.2.3 China Neurological Disorder Drugs Market Share by Type (2018-2029)
8.3 China Neurological Disorder Drugs Market Size by Application
8.3.1 China Neurological Disorder Drugs Market Size by Application (2018-2023)
8.3.2 China Neurological Disorder Drugs Market Size by Application (2024-2029)
8.3.3 China Neurological Disorder Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neurological Disorder Drugs Market Size (2018-2029)
9.2 Asia Neurological Disorder Drugs Market Size by Type
9.2.1 Asia Neurological Disorder Drugs Market Size by Type (2018-2023)
9.2.2 Asia Neurological Disorder Drugs Market Size by Type (2024-2029)
9.2.3 Asia Neurological Disorder Drugs Market Share by Type (2018-2029)
9.3 Asia Neurological Disorder Drugs Market Size by Application
9.3.1 Asia Neurological Disorder Drugs Market Size by Application (2018-2023)
9.3.2 Asia Neurological Disorder Drugs Market Size by Application (2024-2029)
9.3.3 Asia Neurological Disorder Drugs Market Share by Application (2018-2029)
9.4 Asia Neurological Disorder Drugs Market Size by Region
9.4.1 Asia Neurological Disorder Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Neurological Disorder Drugs Market Size by Region (2018-2023)
9.4.3 Asia Neurological Disorder Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Neurological Disorder Drugs Introduction
11.1.4 Novartis Revenue in Neurological Disorder Drugs Business (2018-2023)
11.1.5 Novartis Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neurological Disorder Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Neurological Disorder Drugs Introduction
11.3.4 Merck & Co. Revenue in Neurological Disorder Drugs Business (2018-2023)
11.3.5 Merck & Co. Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Neurological Disorder Drugs Introduction
11.4.4 Bayer Revenue in Neurological Disorder Drugs Business (2018-2023)
11.4.5 Bayer Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Neurological Disorder Drugs Introduction
11.5.4 AstraZeneca Revenue in Neurological Disorder Drugs Business (2018-2023)
11.5.5 AstraZeneca Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Neurological Disorder Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2018-2023)
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Neurological Disorder Drugs Introduction
11.7.4 Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2018-2023)
11.7.5 Teva Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Neurological Disorder Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antipsychotic
Table 3. Key Players of Hypnotic & Sedative
Table 4. Key Players of Analgesics
Table 5. Key Players of Anticoagulants
Table 6. Key Players of Others
Table 7. Global Neurological Disorder Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Neurological Disorder Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Neurological Disorder Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neurological Disorder Drugs Market Share by Region (2018-2023)
Table 11. Global Neurological Disorder Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Neurological Disorder Drugs Market Share by Region (2024-2029)
Table 13. Neurological Disorder Drugs Market Trends
Table 14. Neurological Disorder Drugs Market Drivers
Table 15. Neurological Disorder Drugs Market Challenges
Table 16. Neurological Disorder Drugs Market Restraints
Table 17. Global Neurological Disorder Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neurological Disorder Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Neurological Disorder Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
Table 20. Global Neurological Disorder Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Neurological Disorder Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Neurological Disorder Drugs, Headquarters and Area Served
Table 23. Global Key Players of Neurological Disorder Drugs, Product and Application
Table 24. Global Key Players of Neurological Disorder Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neurological Disorder Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Neurological Disorder Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neurological Disorder Drugs Revenue Share by Application (2018-2023)
Table 32. Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Neurological Disorder Drugs Revenue Share by Application (2024-2029)
Table 34. North America Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Neurological Disorder Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Neurological Disorder Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Neurological Disorder Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Neurological Disorder Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Neurological Disorder Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Neurological Disorder Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Neurological Disorder Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Neurological Disorder Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Neurological Disorder Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Neurological Disorder Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Neurological Disorder Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Neurological Disorder Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Neurological Disorder Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Neurological Disorder Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Neurological Disorder Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Neurological Disorder Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Neurological Disorder Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neurological Disorder Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Neurological Disorder Drugs Product
Table 69. Novartis Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Neurological Disorder Drugs Product
Table 74. GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 75. GlaxoSmithKline Recent Developments
Table 76. Merck & Co. Company Details
Table 77. Merck & Co. Business Overview
Table 78. Merck & Co. Neurological Disorder Drugs Product
Table 79. Merck & Co. Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 80. Merck & Co. Recent Developments
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Neurological Disorder Drugs Product
Table 84. Bayer Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 85. Bayer Recent Developments
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Neurological Disorder Drugs Product
Table 89. AstraZeneca Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 90. AstraZeneca Recent Developments
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Neurological Disorder Drugs Product
Table 94. Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 95. Boehringer Ingelheim Recent Developments
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Neurological Disorder Drugs Product
Table 99. Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2018-2023) & (US$ Million)
Table 100. Teva Pharmaceutical Recent Developments
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurological Disorder Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Neurological Disorder Drugs Market Share by Type: 2022 VS 2029
Figure 3. Antipsychotic Features
Figure 4. Hypnotic & Sedative Features
Figure 5. Analgesics Features
Figure 6. Anticoagulants Features
Figure 7. Others Features
Figure 8. Global Neurological Disorder Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Neurological Disorder Drugs Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Neurological Disorder Drugs Report Years Considered
Figure 13. Global Neurological Disorder Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Neurological Disorder Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Neurological Disorder Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Neurological Disorder Drugs Market Share by Players in 2022
Figure 17. Global Top Neurological Disorder Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2022
Figure 19. North America Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Neurological Disorder Drugs Market Share by Type (2018-2029)
Figure 21. North America Neurological Disorder Drugs Market Share by Application (2018-2029)
Figure 22. North America Neurological Disorder Drugs Market Share by Country (2018-2029)
Figure 23. United States Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Neurological Disorder Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Neurological Disorder Drugs Market Share by Type (2018-2029)
Figure 27. Europe Neurological Disorder Drugs Market Share by Application (2018-2029)
Figure 28. Europe Neurological Disorder Drugs Market Share by Country (2018-2029)
Figure 29. Germany Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Neurological Disorder Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Neurological Disorder Drugs Market Share by Type (2018-2029)
Figure 37. China Neurological Disorder Drugs Market Share by Application (2018-2029)
Figure 38. Asia Neurological Disorder Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Neurological Disorder Drugs Market Share by Type (2018-2029)
Figure 40. Asia Neurological Disorder Drugs Market Share by Application (2018-2029)
Figure 41. Asia Neurological Disorder Drugs Market Share by Region (2018-2029)
Figure 42. Japan Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Neurological Disorder Drugs Market Share by Country (2018-2029)
Figure 52. Brazil Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Neurological Disorder Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 60. Merck & Co. Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 62. AstraZeneca Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Neurological Disorder Drugs Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Loratadine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Loratadine market size was valued at US$ 138.8 million in 2023. With growing demand in downstream market, the Loratadine is forecast to a readjusted size of US$ 175.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Loratadine market. Loratadine are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Allergy Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Allergy Rhinitis Drugs market: According to our latest research, the global Allergy Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergy Rhinitis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overrea......

Global Loratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Loratadine market: According to our latest research, the global Loratadine market looks promising in the next 5 years. As of 2022, the global Loratadine market was estimated at USD 145.21 million, and it's anticipated to reach USD 210.61 million in 2028, with a CAGR of 6.39% during the forecast years. Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching,......

Global Desloratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Desloratadine market: According to our latest research, the global Desloratadine market looks promising in the next 5 years. As of 2022, the global Desloratadine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Desloratadine market, with a sys......

Global Clarityne Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Clarityne market: According to our latest research, the global Clarityne market looks promising in the next 5 years. As of 2022, the global Clarityne market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clarityne market, with a systematical descri......

Global Allergic Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Allergic Rhinitis Drugs market: According to our latest research, the global Allergic Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergic Rhinitis Drugs market was estimated at USD 3956.8 million, and it's anticipated to reach USD 5997.75 million in 2028, with a CAGR of 7.18% during the forecast years. Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous sub......

Global Desloratadine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 107

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis. The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Desloratadine is estimated to increase from $ million......

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 96

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson's Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing ris......

Global Allergic Rhinitis Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 125

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. The global Allergic Rhinitis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs